---
title: Consultancy Services
format: html
css: styles.css
---

Dr. Declan King offers strategic advisory services for pharmaceutical, biotech, and academic partners. Leveraging 20+ years of research leadership, he provides specialized guidance on de-risking neurodegenerative pipelines through advanced biomarker integration and translational study design.

*Engagements are tailored to project scope and specific development milestones.*

**Areas of Engagement:**

:::::: services-container
::: service-card
### Translational Biomarker Strategy

Strategic guidance on the selection and validation of synaptic biomarkers (such as SV2A PET) for Phase I/II neurodegeneration programs. I help sponsors establish objective evidence of target engagement.
:::

::: service-card
### Synaptic Resilience & Study Design

Advisory on the design and interpretation of studies investigating synaptic preservation. I provide expertise in bridging post-mortem molecular data with in-vivo imaging endpoints to de-risk drug development.
:::

::: service-card
### Scientific Advisory & Peer Review

High-level consultancy for research project planning, trial methodology, and publication strategy, leveraging 20+ years of academic and industry-facing research experience.
:::
::::::

<p class="services-note">

*Ready to integrate advanced synaptic biomarkers into your next program?*
**Contact Dr. Declan King** to discuss your project requirements and receive a tailored technical proposal.

**Professional Disclaimer**
Dr. Declan King provides strategic neuroscience consultancy and research advisory services only. All insights and deliverables are intended for informational and research purposes and **do not constitute medical advice, diagnosis, or treatment.** Engagement terms and investment are determined by project scope and technical complexity.

</p>
